Assignee
SAXENA UDAY
US·1 granted patent·2 pending applications·0 citations·filing 2009–2014
Top patents by PatentIndex Score
3 records- 0147US2014322320A1Novel compositions for emesis control in cancer patients undergoing chemotherapy and methods thereofSAXENA UDAY·Filed 2014·Application pending·0 cites
- 0245US8541435B2Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)SAXENA UDAY·Filed 2009·Granted Sep 24, 2013·0 cites·6 claims
- 0345US2013338199A1Novel Niacin Compositions for Reduction of Amyloid Beta Peptide 42 (AB42) Production and for Treatment of Alzheimer's DiseaseSAXENA UDAY·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SAXENA UDAY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →